Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kevin J. Craten"'
Autor:
Afiba Manza-A Agovi, Caitlin T. Thompson, Kevin J. Craten, Esther Fasanmi, Meng Pan, Rohit P. Ojha, Erika L. Thompson
Publikováno v:
Implementation Science Communications, Vol 5, Iss 1, Pp 1-11 (2024)
Abstract Background Long-acting injectable cabotegravir plus rilpivirine (LAI CAB/RPV) has several potential benefits over daily oral formulations for HIV treatment, including the potential to facilitate long-term adherence and reduce pill fatigue. W
Externí odkaz:
https://doaj.org/article/00cf97ea2cd54d16bfcb2508621911db
Autor:
Afiba Manza-A. Agovi, Ifedioranma Anikpo, Matthew J. Cvitanovich, Kevin J. Craten, Eve O. Asuelime, Rohit P. Ojha
Publikováno v:
Preventive Medicine Reports, Vol 20, Iss , Pp 101266- (2020)
Safety-net health systems are a primary source of care for socioeconomically disadvantaged individuals who may be eligible for HIV pre-exposure prophylaxis (PrEP) and are priority groups under the Ending the HIV Epidemic (EHE) initiative. Nevertheles
Externí odkaz:
https://doaj.org/article/361942df9b6441108ebea7dbcbe8694f
Autor:
Yan Lu, Aaron W. Gehr, Ifedioranma Anikpo, Rachel J. Meadows, Kevin J. Craten, Rim Bannout, Kalyani Narra, Anuradha Lingam, Bhavna Tanna, Bassam Ghabach, Rohit P. Ojha
Publikováno v:
Cancer Research. 82:P5-14
Background Current knowledge of cardiotoxicity risk after breast cancer treatment with anthracyclines or trastuzumab is largely derived from cohorts that under-represent socioeconomically disadvantaged patients. Cardiotoxicity risk among socioeconomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7195a2f54d254fe131aea6b5195524c4
https://doi.org/10.1158/1538-7445.sabcs21-p5-14-21
https://doi.org/10.1158/1538-7445.sabcs21-p5-14-21
Autor:
Yan Lu, Aaron W. Gehr, Ifedioranma Anikpo, Rachel J. Meadows, Kevin J. Craten, Kalyani Narra, Anuradha Lingam, Sandeep Kamath, Bhavna Tanna, Bassam Ghabach, Rohit P. Ojha
Publikováno v:
Breast cancer research and treatment. 195(3)
Purpose Evidence of cardiotoxicity risk related to anthracycline or trastuzumab exposure is largely derived from breast cancer cohorts that under-represent socioeconomically marginalized women, who may be at increased risk of cardiotoxicity because o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cce7107e7dd22d34890a832a2b033c88
https://pubmed.ncbi.nlm.nih.gov/35971056
https://pubmed.ncbi.nlm.nih.gov/35971056
Autor:
Kevin J. Craten, Afiba Manza-A. Agovi, Matthew J. Cvitanovich, Rohit P. Ojha, Ifedioranma Anikpo, Eve O. Asuelime
Publikováno v:
Preventive Medicine Reports, Vol 20, Iss, Pp 101266-(2020)
Preventive Medicine Reports
Preventive Medicine Reports
Highlights • Little is known about barriers to PrEP prescribing in safety-net settings. • We identified low provider knowledge of PrEP as a barrier to PrEP prescribing. • PrEP eligibility, side effects and adherence concerns were key unmet know
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c5458890261126418a9bc9ee14ed7dc
http://www.sciencedirect.com/science/article/pii/S2211335520302242
http://www.sciencedirect.com/science/article/pii/S2211335520302242
Autor:
Kevin J. Craten, Afiba Manza-A. Agovi, Rohit P. Ojha, Matthew J. Cvitanovich, Ifedioranma Anikpo
Publikováno v:
Annals of Epidemiology. 49:77
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::034808569d604a5e173e45cf3fc5926e
https://doi.org/10.1016/j.annepidem.2020.05.023
https://doi.org/10.1016/j.annepidem.2020.05.023